Author

Angela M. Cooper

Observed names: A Cooper, A. Cooper, A. M. Cooper, Angela Cooper, Cooper, A.

Institution: University Hospitals of North Midlands NHS Trust

Observed institutions: University of Wolverhampton, Rush University Medical Center, Centers for Disease Control and Prevention, Dalhousie University, University of Toronto, University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital, Rush Copley Foundation, Dewsbury and District Hospital, Royal College of Physicians, Rush University, Royal College of General Practitioners, Medical Research Council

ORCID: 0000-0003-0536-9723

Observed ORCID: 0000-0003-0536-9723

OpenAlex ID: A5067252806

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

2023 · PK Judge, N Staplin, et al. · The Lancet Diabetes & Endocrinology · 123

PDF

Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance

2008 · Angela Cooper, Norma O’Flynn · BMJ · 91

Coursework Marks High, Examination Marks Low: Discuss

2002 · Paul Bridges, Angela Cooper, et al. · Assessment & Evaluation in Higher Education · 83

Short-term psychodynamic psychotherapy for functional somatic disorders: A systematic review and meta-analysis of within-treatment effects

2021 · Allan Abbass, Mark A. Lumley, et al. · Journal of Psychosomatic Research · 76

PDF

Short-Term Psychodynamic Psychotherapy for Functional Somatic Disorders: A Meta-Analysis of Randomized Controlled Trials

2020 · Allan Abbass, Joel Town, et al. · Psychotherapy and Psychosomatics · 75

Assessment of recent onset chest pain or discomfort of suspected cardiac origin: summary of NICE guidance

2010 · A. Cooper, A. Timmis, et al. · BMJ · 62

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

PDF

1999 · Paul Bridges, Bernard Bourdillon, et al. · Assessment & Evaluation in Higher Education · 40

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

PDF

Analysis of the Current Status of Public Health Practice in Local Health Departments

1995 · Jane Suen, Gregory M. Christenson, et al. · American Journal of Preventive Medicine · 25

Implementing a Psychotherapy Service for Medically Unexplained Symptoms in a Primary Care Setting

2017 · Angela Cooper, Allan Abbass, et al. · Journal of Clinical Medicine · 24

PDF

The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?

2020 · Steven J. Smith, John Busby, et al. · ERJ Open Research · 17

PDF

Experiential Dynamic Therapy: A Preliminary Investigation Into the Effectiveness and Process of the Extended Initial Session

2014 · K. Aafjes-van Doorn, J. Macdonald, et al. · Journal of Clinical Psychology · 13

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

PDF

Clinical- and cost-effectiveness of intensive short-term dynamic psychotherapy for chronic pain in a tertiary psychotherapy service

2020 · Peter Lilliengren, Angela Cooper, et al. · Australasian Psychiatry · 12

Impact of a Wellness Leadership Intervention on the Empathy, Burnout, and Resting Heart Rate of Medical Faculty

2023 · Debra A. Gilin, Gregory G. Anderson, et al. · Mayo Clinic Proceedings Innovations Quality & Outcomes · 11

PDF

Patients’ affective processes within initial experiential dynamic therapy sessions.

2016 · Katie Aafjes-van Doorn, Peter Lilliengren, et al. · Psychotherapy · 8

Implementing the Clinical Nurse Leader Role: A Care Model Centered on Innovation, Efficiency, and Excellence

2015 · Denise M. Wienand, Prachi R. Shah, et al. · Nurse Leader · 8

Who speaks “kid?” How experience with children does (and does not) shape the intelligibility of child speech.

2023 · Madeleine E. Yu, Angela Cooper, et al. · Journal of Experimental Psychology Human Perception & Performance · 7

Secondary prevention of ischaemic cardiac events.

2011 · Jane S Skinner, Angela Cooper · PubMed · 7

Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O. Abani, A. Abbas, et al. · EClinicalMedicine · 5

8. Systemic Family Therapy

2015 · Anna Tickle, Michael Rennoldson, et al. · 4

Mixed-methods evaluation of an enhanced asthma biologics clinical pathway in the West Midlands UK

2024 · Sarah Damery, Janet Jones, et al. · npj Primary Care Respiratory Medicine · 3

Evidence based secondary prevention following a myocardial infarction (MI): the new NICE guideline

2007 · R. Minhas, A. Cooper, et al. · International Journal of Clinical Practice · 3

Emergency management of anaphylaxis and the impact of the new UK advanced life support guidelines

2025 · Mahmoud Elshehawy, Madhavi Kadambi, et al. · Clinical Medicine · 1

Works count: 49

Citation count: 794

H-index: 13

I10-index: 16